Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2018-09-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes, including changes in business scope and company bylaws, as well as the election of a new chairman and legal representative. It references prior announcements for these changes and provides details about the updated business license. The document is short (1146 characters) and does not contain financial statements or detailed financial data. It is an official regulatory announcement about corporate administrative changes rather than a financial report or detailed management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-09-17 Chinese
关于回购公司股份的预案
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a company's plan to repurchase its own shares, including the purpose, method, price range, funding source, quantity, duration, and potential impact on the company's capital structure. It also includes management analysis, risk warnings, and authorization requests related to the share buyback. The content focuses on the company's share repurchase plan and related corporate actions rather than financial results, earnings, or regulatory certifications. This matches the definition of a 'Transaction in Own Shares' filing, which covers share repurchase announcements and plans.
2018-09-17 Chinese
第三届董事会第十二次临时会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of the company, specifically regarding a share repurchase (buyback) plan. It includes voting results, authorization requests for the board to execute the buyback, and plans to convene a shareholders meeting to approve these matters. The content focuses on corporate governance decisions and capital structure changes related to share repurchase. It is not a full financial report, earnings release, or audit report. It is also not a simple announcement of a report publication or a certification. The document is primarily about the board's decisions and plans for share repurchase, which fits the category of Transaction in Own Shares (POS). The document length is about 3080 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the best classification is POS (Transaction in Own Shares).
2018-09-17 Chinese
公司章程（2018年8月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 迪瑞医疗科技股份有限公司. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, and other governance-related matters. It references Chinese company law and securities law, and includes detailed provisions on shareholder meetings, board responsibilities, and corporate governance. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a governance document outlining the internal rules and structure of the company. Therefore, the document fits the category of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance charter, not an announcement or summary.
2018-08-27 Chinese
第三届董事会第十一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at a board meeting, including the resignation of the chairman, election of a new chairman, appointment of a committee member, and amendments to the company bylaws. It contains no financial data or report content but focuses on changes in the board and management structure. The document length is short (1644 characters), and it is clearly a formal announcement of board/management changes. Therefore, it fits the category of Board/Management Information (MANG).
2018-08-27 Chinese
关于修改《公司章程》并办理工商登记变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company about changes to its Articles of Association (公司章程) and related corporate registration updates. It details the adjustment of the number of board members and corresponding amendments to the Articles. It also mentions that the board has approved the proposal and that it will be submitted to the shareholders' meeting for approval. There is no financial data, no report attached or referenced as being published, and no mention of earnings, audit, or other financial reports. The document is a formal announcement of board-related changes and corporate governance amendments, but it is not a full governance report or management report. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about corporate governance changes that does not fit other specific categories like MANG (which is for board or management changes, but this is about the Articles and registration changes, not personnel changes). The document length is short and it is an announcement, not a report itself.
2018-08-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.